PSP-94: Use for treatment of hypercalcemia and bone metastasis

Details for Australian Patent Application No. 2002340681 (hide)

International Classifications

Event Publications

27 February 2003 Complete Application Filed

Priority application(s): 2,361,736 08.11.01 CA

24 July 2003 Application Open to Public Inspection

Published as AU-B-2002340681

2 November 2006 Change of Name(s) of Applicant(s), Section 104

Procyon Biopharma Inc. The name of the applicant has been changed to Ambrilla Biopharma Inc. 2004

4 January 2007 Change of Name(s) of Applicant(s), Section 104

Ambrila Biopharma Inc. The name of the applicant has been changed to Ambrilia Biopharma Inc.

13 September 2007 Application Accepted

Published as AU-B-2002340681

17 January 2008 Standard Patent Sealed

4 June 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.